logo-loader

FastForward Innovations reveals key updates for portfolio companies Factom and EMMAC Life Sciences

Published: 10:29 30 Jul 2020 EDT

FastForward Innovations Limited (LON:FFWD) Ed McDermott updated Proactive on the status of two of its investment companies, Factom Inc EMMAC Life Sciences. McDermott says for Factom, it has reached a provisional agreement with Factom whereby it is proposed that FastForward’s US$6mln SAFE note shall be converted to equity by the issue of 5.9mln new shares in Factom.

On EMMAC, McDermott says it has secured approval from Spanish health authorities to cultivate medical cannabis at its Medalchemy manufacturing site in Alicante, and added more color on its NASDAQ listing through its merger with SPAC Andina.

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

1 hour, 38 minutes ago